Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20215686 20155653 1.7 100.6 Palliative (P) 2016-12-19 2017-01-16 Trial Unspecified N N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100581575
20215689 20155654 1.69 59.5 Palliative (P) 2019-04-12 2019-04-25 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100573998
20215690 20155655 1.6 56.3 Palliative (P) 2017-02-16 2017-06-20 Sorafenib 02 N SORAFENIB 100583102
20215691 20155656 1.64 null null 2019-02-24 2019-04-09 Trial Unspecified 02 N OXALIPLATIN + RALTITREXED 101423484
20215693 20155657 1.66 69.6 Palliative (P) 2019-07-12 2019-07-12 EOX 99 N CETUXIMAB + IRINOTECAN + MDG 100355171
20215694 20155658 1.92 81.9 Palliative (P) 2017-09-26 2017-10-07 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101437009
20215704 20155659 1.66 81.4 Palliative (P) 2020-08-07 2020-08-29 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100902126
20215707 20155660 null null Palliative (P) 2019-08-28 2019-09-08 Oxaliplatin + Raltitrexed 02 N OXALIPLATIN + RALTITREXED 101813519
20215709 20155661 1.6 58.5 Palliative (P) 2018-04-06 2018-05-03 EOX 02 N CETUXIMAB + IRINOTECAN + MDG 100495429
20215710 20155662 1.7 86.9 Neo-adjuvant (N) 2017-05-03 2017-05-22 EOX N N CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100807570
20215714 20155663 1.58 40.4 Palliative (P) 2019-02-17 2019-03-11 EOX N Y FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100398081
20215715 20155664 1.62 78 Palliative (P) 2019-07-02 2019-07-14 EOX 02 N TRIAL 101268376
20215716 20155665 1.84 47.3 Palliative (P) 2018-04-25 2018-05-01 Oxaliplatin + Raltitrexed Y N OXALIPLATIN + RALTITREXED 101488633
20215717 20155666 1.57 65.4 Neo-adjuvant (N) 2017-03-01 2017-03-14 EOX N N EOX 100128154
20215721 20155667 null 91 Palliative (P) 2020-03-30 2020-03-31 Capecitabine 35days + RT 02 N CAPECITABINE + RT 100662723
20215725 20155668 1.67 70.1 Palliative (P) 2019-01-20 2019-03-13 Capecitabine 35days + RT N N CAPECITABINE + RT 101322806
20215726 20155669 1.78 85.9 null 2019-04-18 2019-04-18 EOX 2 null EOX 101127910
20215731 20155670 1.46 120 null 2017-06-24 2017-07-23 EOX 02 Y EOX 100880529
20215732 20155671 1.82 48 null 2017-12-31 2018-01-27 EOX N N CETUXIMAB + IRINOTECAN + MDG 101453556
20215734 20155672 1.67 77.6 Adjuvant (A) 2017-12-06 2017-12-16 Trial Unspecified 02 N TRIAL 101039427
20215735 20155673 1.61 62.8 Neo-adjuvant (N) 2018-03-02 2018-03-09 Oxaliplatin + Raltitrexed 01 N OXALIPLATIN + RALTITREXED 101765996
20215738 20155674 null 84.6 Neo-adjuvant (N) 2020-07-04 2020-07-11 IRINOTECAN + MDG + PANITUMUMAB 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100982184
20215740 20155675 1.75 85 Palliative (P) 2020-02-28 2020-03-10 Trial Unspecified 02 N OXALIPLATIN + RALTITREXED 101858357
20215752 20155676 1.59 61.9 Palliative (P) 2016-12-24 2020-06-14 Cetuximab + FOLFIRI cycle1 N N CETUXIMAB + IRINOTECAN + MDG 100754588
20215753 20155677 1.75 61 Neo-adjuvant (N) null 2019-10-19 EOX 02 N OXALIPLATIN + RALTITREXED 100945170
20215756 20155678 1.59 43.5 Palliative (P) 2018-10-16 2018-10-24 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100675504
20215757 20155679 1.91 77.1 Palliative (P) 2021-03-14 2021-04-04 Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN 02 N CETUXIMAB + IRINOTECAN + MDG 101776537
20215760 20155680 1.78 47.8 Neo-adjuvant (N) 2020-02-12 2020-02-26 EOX 2 N TRIAL 101092492
20215767 20155681 1.84 84.75 Palliative (P) 2018-09-30 2018-10-28 Cetuximab + FOLFIRI cycle 2 onwards 02 N CETUXIMAB + IRINOTECAN + MDG 100761428
20215774 20155682 1.58 79.5 Palliative (P) 2020-12-04 2021-01-05 EOX 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 100703986
20215775 20155683 1.78 51.2 Palliative (P) 2020-01-30 2020-01-30 Capecitabine 42days + RT N N CAPECITABINE + RT 101280717
20215776 20155684 1.6 114.4 Palliative (P) 2020-01-03 2020-01-17 Trial Unspecified N N TRIAL 101590620
20215778 20155685 1.63 48 Palliative (P) 2017-03-16 2017-06-28 GO2 TRIAL 2 N TRIAL 100912373
20215780 20155686 1.87 74.3 Palliative (P) 2020-08-26 2020-08-31 IRINOTECAN + MDG + PANITUMUMAB 02 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101515440
20215781 20155687 1.46 71.4 null 2016-10-17 2016-10-17 IRINOTECAN + MDG + PANITUMUMAB 01 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101565419
20215788 20155688 1.91 84.7 Palliative (P) 2019-09-10 2019-11-15 IRINOTECAN + MDG + PANITUMUMAB 99 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101832335
20215790 20155689 1.7 82.8 Curative (C) 2020-03-29 2020-04-26 Oxaliplatin + Raltitrexed 02 Y OXALIPLATIN + RALTITREXED 101796850
20215791 20155690 1.58 45.7 Palliative (P) 2017-08-23 2017-08-31 Panitumumab + Irinotecan + MdG 02 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101194513
20215794 20155691 1.63 54.3 03 2017-03-30 2017-04-08 Sorafenib 02 N SORAFENIB 100733981
20215795 20155692 1.63 48.7 null 2022-04-03 2022-04-15 EOX 2 Y CETUXIMAB + IRINOTECAN + MDG 101118523
20215796 20155693 1.67 100 null 2019-12-05 2019-12-06 CETUXIMAB + IRINOTECAN + MDG N N CETUXIMAB + IRINOTECAN + MDG 100380832
20215797 20155694 1.79 53 Palliative (P) 2016-09-13 2016-09-13 EOX 99 Y CETUXIMAB + FLUOROURACIL + OXALIPLATIN 100481215
20215799 20155695 1.67 112 Palliative (P) 2017-06-04 2017-06-16 IRINOTECAN + MDG + PANITUMUMAB 01 N FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101218620
20215802 20155696 1.62 76.4 Palliative (P) 2017-08-03 2017-08-26 Sorafenib 02 null SORAFENIB 100572214
20215807 20155697 1.78 73.9 null 2017-11-01 2017-11-08 Sorafenib 02 null SORAFENIB 100663324
20215808 20155698 1.62 64.2 Neo-adjuvant (N) null 2020-05-25 Trial Unspecified 1 N TRIAL 100869446
20215810 20155699 1.7 107 Palliative (P) 2019-01-27 2019-04-02 CETUXIMAB + IRINOTECAN + MDG 2 N EOX 100943986
20215811 20155700 1.82 68.2 Adjuvant (A) 2020-07-28 2020-08-17 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 02 null FLUOROURACIL + IRINOTECAN + PANITUMUMAB 101580733
20215812 20155701 1.79 0 Curative (C) 2018-09-22 2018-09-22 Trial Unspecified N N TRIAL 101412970
20215813 20155702 1.74 53.6 Palliative (P) 2019-04-28 2019-05-23 Oxaliplatin + Raltitrexed 02 N OXALIPLATIN + RALTITREXED 100361771